Pancreatic Cancer Research

ResearcherMemorial Sloan Kettering Cancer CenterActive in the last 2 years

John Laurence Humm

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4245-5591; OpenAlex author ID A5050136149; NIH RePORTER profile ID 1858943. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 5)
Trials
0
Grants
1
Labs led
1
Collaborators
12
Papers, trials and grants by year

2015: 2 papers · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 grant · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 7

  1. Tumor Microenvironment: Insights from Multiparametric MRI in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers18020273↗
  2. Analysis of capecitabine metabolites in conjunction with digital autoradiography in a murine model of pancreatic cancer suggests extensive drug penetration thr… Last author DOI 10.1002/prp2.898↗
  3. Predicting Gemcitabine Delivery by 18F-FAC PET in Murine Models of Pancreatic Cancer. Last author DOI 10.2967/jnumed.120.246926↗
  4. Comparing the intra-tumoral distribution of Gemcitabine, 5-Fluorouracil, and Capecitabine in a murine model of pancreatic ductal adenocarcinoma. Last author DOI 10.1371/journal.pone.0231745↗
  5. In Vitro and In Vivo Comparison of Gemcitabine and the Gemcitabine Analog 1-(2'-deoxy-2'-fluoroarabinofuranosyl) Cytosine (FAC) in Human Orthotopic and Genetic… Last author DOI 10.1007/s11307-017-1078-6↗
  6. Reverse-Contrast Imaging and Targeted Radiation Therapy of Advanced Pancreatic Cancer Models. Co-author DOI 10.1016/j.ijrobp.2015.06.001↗
  7. Distribution of Gemcitabine Is Nearly Homogenous in Two Orthotopic Murine Models of Pancreatic Cancer. Last author DOI 10.1089/cbr.2015.1869↗

Grants 1

  1. Imaging drug uptake and distribution in chemoradiation therapy of pancreatic cancer R01CA194321↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. James Russell · 7 shared papers, 2015–2026 · strength 0.88
  2. Nagavarakishore Pillarsetty · 4 shared papers, 1 shared grant, 2017–2022 · strength 0.72
  3. Kenneth H. Yu · 2 shared papers, 1 shared grant, 2019–2021 · strength 0.49
  4. Maeve Aine Lowery · 2 shared papers, 1 shared grant, 2015–2019 · strength 0.37
  5. Louise M. Fanchon · 2 shared papers, 2020–2022 · strength 0.28
  6. Amita Shukla‐Dave · 1 shared paper, 2026 · strength 0.28
  7. Eileen Mary O'Reilly · 1 shared paper, 2026 · strength 0.28
  8. Ramesh Paudyal · 1 shared paper, 2026 · strength 0.28
  9. Richard Kinh Gian · 1 shared paper, 2026 · strength 0.28
  10. Abraham Wu · 1 shared grant, 2019 · strength 0.25
  11. Robin M. Kramer · 3 shared papers, 2015–2017 · strength 0.20
  12. Daniel L.J. Thorek · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.